Abstract
Individual differences in drug effects are largely influenced by genetic polymorphism. Therefore, detection of drug-related gene polymorphisms is critical for achieving gene-directed personalized medicine. This chapter gives a brief introduction to the commonly used methods for detecting gene polymorphisms, focusing on their detection principles and detection technology platforms. By understanding the principles of these genetic polymorphism detection techniques, it is helpful to select an appropriate platform for pharmacogenomics-related research as well as personalized medicine.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
11.1 Introduction
Genetic variation is one of the reasons why individuals have different responses to the same drug [1]. For instance, CYP2C19 gene polymorphism (rs4244285) affects the metabolism of clopidogrel [2] and the proton pump inhibitor omeprazole [3], thereby affecting their efficacy. Besides gene polymorphism, some somatic mutations have become important markers for guiding the use of targeted anti-tumor drugs for individual patients [4]. With the wide application of next generation sequencing technology, more and more drug-related gene mutations were found, and some genetic variants have become effective targets for individualized drugs in clinical applications [5], promoting the advances of precision medicine. Consequently, accurate and reliable tools for detecting genetic variations are required both in scientific research and clinical applications. Currently there are various kinds of methods based on different principles available for genotyping in pharmacogenomics, such as allele-specific probe hybridization, allele-specific primer extension, allele-specific enzyme digestion and ligation. Also various detection platforms have been developed for the corresponding methods. Here we briefly introduce some typical genotyping technologies in the case of principles and corresponding detection platforms.
11.2 Principles of Genotyping Technologies
11.2.1 Allele-Specific Hybridization
Hybridization is an intrinsic feature of DNA. Two oligonucleotide fragments can be hybridized into a double-stranded nucleic acid fragment by base pairing under the conditions of suitable ionic strength and an appropriate temperature (Fig. 11.1). This is a reversible process when the temperature rises to a certain extent, the two oligonucleotide strands are denatured into single-stranded nucleic acid fragments. The temperature, at which half of the double-strand DNA denatured, is defined as melting temperature (Tm) of the DNA. The Tm is mainly dependent on the ionic strength of the solution, the concentration of the oligonucleotide, and the sequences of the oligonucleotide. Commonly, one-base mismatched DNA has a lower Tm than the complementary DNA, thus it is difficult to form duplex for the mismatched DNA at Tm of the complementary DNA due to the kinetic instability. Therefore, the single-base difference between alleles in SNPs could be distinguished on a suitable temperature via detecting hybridization behaviors. Many strategies were proposed for monitoring the hybridization behaviors, such as measuring fluorescence signal changes of double-stranded chimeric fluorescent dyes [6] and fluorescent probe hybridization [7]. Accordingly, many technology platforms based on the principle of allele-specific hybridization were developed, such as high resolution melting curve analysis (HRM) [8], SNP array [9], molecular beacon-based SNP detection [10]. The key point of allele-specific hybridization-based technology is how to ensure the high specificity of the detection. Although single-base difference in nucleic acid sequences results in different Tm values, in some cases the difference in Tm values is so small that it is difficult to ensure the specificity of hybridization. Therefore, the detection conditions should be carefully optimized and precisely controlled, and sometimes the additional additives (dimethyl sulfoxide, betaine, formamide, etc.) or special modifications (locked nucleic acid, peptide nucleic acid, etc.) to the probe are required to improve the specificity of hybridization, which increases the complexity of the experimental setup.
11.2.2 Endonuclease Digestion
An endonuclease is an enzyme that can cleave the nucleotide chain into two parts. Endonucleases usually recognize certain sequences in the nucleotide chain or some special structure formed by oligonucleotides. The specificity of some endonuclease is high enough to distinguish one-base difference in the recognition sequences or structures, so we can use those endonucleases to develop SNP detection assay. The typical genotyping methods based on endonuclease are Invader assay and restriction fragment length polymorphism (RFLP) technology.
Invader assay is depending on flap endonuclease 1 (FEN1) to recognize an invasive structure, which is formed by an upstream probe invading one base into the double-strand region of downstream probe hybridizing to a target DNA (as shown in Fig. 11.2), and cut the 5′-flap fragment from the downstream probe. Because the Tm value of the downstream probes is close to the reaction temperature, the cleaved downstream probe will dissociate from the template and an intact downstream probe will again hybridize with the template to form an invasive structure, triggering a cycle of cleavage. The cleaved flaps can be captured by hairpin fluorescence reporter probe to form invasive structure again, which is recognized by FEN 1, leading to the cleavage of 5′-end of the hairpin probe. The hairpin probe is labeled with a fluorescence reporter molecule and a fluorescence quenching group at the 5′ area. After cleavage, the fluorescent group on the hairpin probe is separated from the quenching group, generating fluorescence signal. Since the Tm value of flap is designed to be close to the reaction temperature, each flap fragment can be dynamically hybridized with many hairpin probes to form the invasive structure, resulting in gradually enhanced fluorescence signals. The specificity of Invader assay is high enough to identify single-base difference in target DNA especially when the different base is the invaded base in the invasive structure.
Invader assay was successfully used to detect many single nucleotide polymorphisms (SNPs) [11,12,13], such as factor V G1691A mutation (rs6025) associated with deep venous embolism [14]. In order to achieve quantitative detection, an invasive reaction-based real-time PCR was proposed by employing Invader assay to identify the PCR amplicons and produce fluorescence signals at each annealing step in PCR cycles [15, 16]. Beneficial from the high specificity of Invader assay, the invasive reaction-based real-time PCR is capable to quantitatively detect 0.1% somatic mutations [15] and 0.05% methylated gene fragment [17].
Polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP) analysis technique combines PCR and RFLP technology to convert RFLP into PCR products-based markers (Fig. 11.3). Firstly, PCR specifically amplifies the DNA fragments containing the mutant base, and then the PCR products are digested by corresponding restriction enzymes. The principle of RFLP is to detect the size of a particular DNA fragment after restriction endonuclease digestion. Point mutations, insertions, and deletions can lead to new generation and removal of restriction sites, or changes in the length of the cleavage products [18], resulting in different patterns of the digested PCR amplicons on electropherogram for the homozygous wild type, the homozygous mutant type, and the heterozygous samples.
Although PCR-RFLP is successfully used to determine genetic diseases-related loci (such as cystic fibrosis) [19] and drug-related SNPs [20], the tedious operation and limited types of restriction endonuclease hinder its applications.
11.2.3 Primer Extension
Many genotyping methods are based on primer extension, such as DNA sequencing [21] and allele-specific extension [22]. The specificity of these methods is mainly dependent on the DNA polymerase, which can specifically incorporate correct dNTPs to the 3′-end of a primer fully complementary to the target DNA. By detecting the type of dNTPs incorporated (DNA mini-sequencing) or designing allele-specific primers (allele-specific PCR), a DNA target can be genotyped.
Most of DNA sequencing methods are based on primer extension (Fig. 11.4). DNA polymerase precisely incorporates a dNTP complementary to target DNA sequence into the 3′-end of a primer. The type of the incorporated dNTP can be identified by measuring the by-product of extension, such as PPi and H+, or detecting the fluorescence signal produced by labeled dNTPs or the extended primer itself. Many technology platforms were used to detect these extension products, for example, DNA chips, DNA sequencers, TOF-MS, and so on.
Besides the high specificity of dNTP incorporation, the recognition specificity of DNA polymerase is also high enough to distinguish one-base mismatch at the 3′-end of the primer. The allele-specific extension method is based on the recognition specificity of DNA polymerase. For SNP detection, two primers, whose 3′-end is respectively complementary to the two base types of the allele, are used. The DNA polymerase only recognizes the matched primer and extends it, thus the allele can be genotyped by measuring extension signals. Allele-specific PCR is the typical technology that uses primer extension to detect DNA mutations.
11.2.4 Allele-Specific Oligonucleotide Ligation
Ligation reaction is another principle widely used in genotyping methods. Ligase catalyzes the formation of phosphodiester bonds between the 5′ phosphate group and the 3′ hydroxyl group of two adjacent oligonucleotides, so the nick of the double-strand DNA can be repaired [23]. The mismatch at the 3′-end or the 5′-end of the adjacent oligonucleotides leads to a very low ligation efficiency. Therefore, we can use this property to design genotyping strategies. There are two typical techniques based on oligonucleotide ligation for gene genotyping: rolling circle amplification (RCA) and multiplex ligation-dependent probe amplification (MLPA).
RCA is an isothermal and efficient enzymatic process driven by unique DNA polymerase (e.g., Phi29 or Bst DNA polymerase), which can generate long single-stranded DNA (ssDNA) with a circularized DNA as template [24]. According to the amplification model, RCA includes three types: (1) linear RCA (LRCA) reaction with single primer [25]; (2) exponential RCA reaction with multiple primers, including hyperbranched RCA (HRCA) [26] and multiprimed RCA [27]; (3) circle-to-circle amplification [28]. As more than 109 copies of amplification product could generate in 90 min, RCA is commonly used for ultrasensitive DNA detection in areas of genomics and diagnostics [29]. For gene genotyping (Fig. 11.5), a long oligonucleotide probe called “padlock probe” is used to hybridize to target DNA, forming a DNA circle with a nick at the end of the probe. The SNP site is located at the 3′-end or the 5′-end of the padlock probe. The matched padlock probe can be ligated by ligase to form an intact circularized DNA probe, which is the template for RCA. The target DNA can be genotyped by detecting the products of RCA with fluorescent-labeled detection probe or fluorescence dye.
MLPA is another genotyping technology based on ligation reaction. In MLPA (Fig. 11.6), a set of probe pairs is used to hybridize to different SNP sites. Each target SNP is designed with a set of MLPA probes containing two adjacent regions of target-specific hybridization sequences [30]. After denaturation, the target DNA could be hybridized with specific MLPA probes, and the adjacent regions of hybridization sequences could be ligated by a thermostable ligase. Thus the ligation probe could be amplified by PCR with a universal primer pair (F and R), resulting in large amounts of amplification products with a unique length (130–480 bp). Then, the amplification products could be further analyzed by electrophoresis according to the unique length. If no target DNA exists, the MLPA probe could not be ligated, leading to the absence of the corresponding signal in the separation peak map of the capillary electrophoresis. The ligation of the MLPA probe is highly specific to discriminate a single-base difference, achieving accurately genotyping. MLPA enables relative quantification for variations of up to 45 SNPs in a single reaction [31].
11.3 Platforms of Genotyping Technologies
11.3.1 Fluorescence Resonance Energy Transfer
Fluorescence resonance energy transfer (FRET) is a mechanism that a donor chromophore may transfer energy to an acceptor chromophore, inducing spectral characteristic change. The efficiency of the energy transfer is dependent on the distance between the donor and acceptor. This property is used to develop research tools in biology and chemistry fields [32]. For genotyping, TaqMan probe and molecular beacon (MB) are commonly used technologies based on FRET.
TaqMan probe is a hydrolysis probe designed to increase the specificity of quantitative PCR. The method was first reported in 1991 by researchers at Cetus Corporation, and the technology was subsequently developed by Roche Molecular Diagnostics for diagnostic assays and by Applied Biosystems for research applications. A typical TaqMan probe is an 18–22-bp oligonucleotide labeled with a reporter fluorophore at the 5′-end and a quencher fluorophore at the 3′-end. As shown in Fig. 11.7, during PCR, the probe anneals specifically to the PCR amplicons and DNA polymerase exhibits its 5′ exonuclease activity to cleave the probe, releasing the reporter molecule away from the close vicinity of the quencher, producing fluorescence signals in each PCR cycle. If the sequences of the probe do not match the PCR amplicons, no cleavage occurs, so that the fluorescence signals remain low intensities. The specificity of TaqMan probe is mainly depending on the specificity of probe hybridization. By carefully designing the probe and optimizing the reaction conditions (especially the annealing temperature), a single-base mismatch can be identified. TaqMan probe enables highly specific and close-tube analysis of PCR amplicons, but the design of the probe and the optimization of reaction conditions are usually tediously. In addition, the specificity of TaqMan probe is not satisfied for somatic mutation detection. Therefore, some modified TaqMan probe, such as Minor Groove Binder (MGB) TaqMan probe [33] and locked nucleic acid (LNA) modified probe [34] are usually used to improve the specificity.
MB is a FRET probe containing a single-strand loop and a double-strands stem formed by the hybridization at the 3′-end and 5′-end of the probe (Fig. 11.8). The reporter fluorophore and the quencher fluorophore are at the 3′-end and 5′-end of the probe, respectively, and close to each other due to the stem when no target DNA exists. The sequence of the loop is complementary to a target DNA sequence. When a target DNA hybridizes to the loop, the stem is opened, and the reporter fluorophore and the quencher fluorophore are separated, producing fluorescence signals. A well-designed MB is sensitive to single-base difference in target DNA, especially when the mismatched base is located in the middle of the loop region [35]. Therefore, MB can be used to detect SNP. Because the reporter fluorophore and the quencher fluorophore are located very closely, the background signals from reporter fluorophore are smaller than TaqMan probe [36]. However, it is difficult for MB to detect somatic mutations as well as TaqMan probe due to the limited specificity of DNA hybridization.
11.3.2 Microarray
Microarray is a DNA sequence variation detection tool that was developed at the end of the last century to meet the needs of large-scale gene function research in the post-genomic era. It has the advantages of high-throughput, simple and convenient operation, easy to achieve automation and low cost, and provides an efficient detection method for high-throughput genotyping.
The principle of microarray is to use an in-situ synthesis or cross-linking method to immobilize tens of thousands of DNA probes onto the surface of the carrier in an orderly manner to produce an array of DNA probes. Then, labeled samples are hybridized to the immobilized probes followed by measuring the intensity of hybridization signals at each probe location to identify the target DNA. There are three strategies for microarray to achieve genotyping.
The first strategy is hybridization-based genotyping microarray [37]. The amplified PCR products containing SNP loci were spotted and immobilized onto amino-modified glass slides to generate a microarray. Then dual-color fluorescence probes specific to different types of the loci are hybridized to the immobilized PCR products (Fig. 11.9). After washing, the fluorescence signals are detected to read out the SNP genotypes. Although this strategy is simple to operate, the specificity of hybridization is strictly dependent on the reaction conditions. Therefore, the false-positive result usually occurs if the reaction conditions are not optimal.
The second strategy is extension-based microarray [38], in which sequence-specific extension of two immobilized allele-specific primers occurs. According to the fluorescence intensity of each spot, we could read the genotype of a sample (Fig. 11.10).
The third strategy is ligation-based microarray [39]. As shown in Fig. 11.11, the discriminating probe (DP) and the common probe (CP) are designed to hybridize adjacently on the template DNA and are joined by ligase in the presence of a matching template. The discriminating 3′-base can be A, C, T, or G. The reaction is thermally cycled and ligation products will be addressed on microarray spots by the unique ZipCode sequences flanking each CP. Hybridization control probe carries a different label (6-FAM) than the DP (Cy3).
One advantage of using microarrays is that they can be designed to detect a wide diversity of genetic variants. As first demonstrated by Cronin in 1996 [40], oligonucleotide microarray can readily detect many types of variations. Using a modest size oligonucleotide array containing 1480 probes, the investigators were able to detect known deletions, insertions, and base substitutions in the cystic fibrosis transmembrane conductance regulator gene. Another example, Glas [41] used microarrays to predict the risk for breast cancer metastasis in primary breast cancer samples based on the expression pattern of 70 genes. Furthermore, several microarray-based tests that simultaneously examine variations in multiple genes are approved by the FDA and have entered practice.
11.3.3 Mass Spectrometers
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was initially developed for proteomics application studies, while the full potential of nucleic acid analysis was demonstrated in the year of 1995 [42]. Compared with the detection of proteins, the detection of nucleic acids by MALDI-TOF suffers from some problems, such as matrix or traces alkali metal ions leading to the formation of adducts, low sensitivity and resolution of analysis, unstable molecular ion peaks of nucleic acid molecules, and so on. Fortunately, with the continuous improvement in sample preparation and purification technology, MALDI-TOF is also widely used in the detection of DNA, especially for SNP detection [43].
MALDI-TOF MS requires biomolecules to form a co-crystal with a suitable matrix. When a pulsed laser (usually 266 nm or 337 nm) is irradiated onto the crystal, the matrix absorbs energy and the co-crystal is volatilized. In the gas phase, a proton transfer reaction occurs between the matrix and the biomolecule, so that the biomolecule is ionized. The ion beam is then accelerated in an electric field of approximately 30 KV, and then passed through an electric field-free drift tube. Although all ions receive the same kinetic energy in the acceleration zone, the speed of each ion differs due to their different mass-to-charge ratios. Therefore, the time of flight (TOF) of each ion that reaches the detector through the drift tube is different. The molecular weight of each ion can be calculated by the TOF.
For SNP detection, the allele-specific product should be firstly generated and then analyzed by MALDI-TOF MS. Four methods are usually used for generating allele-specific products, including primer extension, probe hybridization, restriction enzyme digestion or ligation. The primer extension reaction is the most widely used method to couple with MALDI-TOF MS for SNP detection. In this method, the target DNA is amplified by PCR and then immediately annealed with an extension primer. The 3′-end of the primer is located upstream of the SNP site, and the single-base extension is performed in the presence of four types of ddNTPs. The ddNTP complementary to the SNP site of the target DNA is introduced into the 3′-end of the primer after extension. The extended primers with different molecular weights can be identified by MALDI-TOF MS. In order to improve the resolution and accuracy, additional mass tags can be introduced on the primers or ddNTPs [44].
Primer extension coupling with MALDI-TOF MS is reliable, flexible, and easy to achieve high-throughput multiple SNP analysis. The MassARRAY® molecular weight array system developed by Sequenom (USA) is the only device that directly detects multiple SNPs by mass spectrometry. It can process two gene chips at the same time, and each chip can detect 384 samples × 15 SNP sites.
11.3.4 Sequencing Platforms
Sequencing is one of the most widely used techniques to reveal the function of genes. The development of precision medicine is beneficial from advances in sequencing technology [45]. Sequencing can directly tell us the sequence information of SNP, so it is the gold standard for SNP detection. The main sequencing technology includes Sanger sequencing, pyrosequencing, and next generation sequencing (NGS).
The first working draft of the human genome was completed by using Sanger sequencing technology. In Sanger sequencing process, the primer extension is performed by using four kinds of fluorophores-labeled dideoxynucleotides (ddNTP) mixed with dNTP, thus the extension stops randomly at the different position on the DNA template, producing the extension products with different length. Then, the extension products are separated by polyacrylamide gel electrophoresis, and the sequence information can be read out according to fluorescence signals and lengths of the products. Sanger sequencing is able to sequence up to 1100 bp of target DNA, but it is unable to detect mosaic alleles below 15–20% [46], which limits its application in somatic mutation detection.
Different from Sanger sequencing, pyrosequencing is based on sequencing-by-synthesis. It employs four enzymes to accurately detect nucleic acid sequences during the synthesis. Four kinds of dNTP are added to the reaction system one by one. If the added dNTP is complemented to the target sequence, DNA polymerase can incorporate the dNTP into the 3′ end of the primer, releasing equal molar of pyrophosphate (PPi). The released PPi is subsequently converted to ATP by ATP sulfurylase and then immediately sensed by luciferase, producing a proportional amount of light. Apyrase is in charge of degrading residual dNTP and ATP to ensure no residual effects on the next dNTP adding. The light signals can be converted to electric signals by photosensitive device, thus the sequence can be detected by measuring the electric signals. Because the signal is proportional to the amount of dNTP incorporated, pyrosequencing can achieve quantitative detection of the target. This property makes pyrosequencing able to detect DNA methylation [47], gene expression [48], and miRNA quantitation [49].
NGS is a high-throughput sequencing technology that emerged in 2005. Several NGS platforms had been developed including 454 FLX pyrosequencing platform, Solexa Genome Analyzer platform, ABI SOLiD sequencer, and Ion Torrent system. The first step of all platforms is fragmentation of the sample DNA, followed by ligation to a common adaptor set for clonal amplification. Sequencing mainly employs two categories: sequencing by ligation (SBL) and sequencing by synthesis (SBS). SOLiD is a ligation-based sequencing platform, while Solexa, 454 FLX pyrosequencing platform, and Ion Torrent system are based on SBS. The advent of NGS has revolutionized biology, genetics, pharmacogenomics research, and the diagnosis and treatment of diseases, leading to the development of precision medicine [50]. Although NGS enables the cost of sequencing one person’s genome fewer than 1000 dollars, the preparation of sequencing library and the data analysis are still tedious. Thus, NGS is suitable for high-throughput detecting thousands of SNPs and genome-wide association study (GWAS), not very useful for the detection of a few known SNP sites.
11.4 Conclusion
Genotyping plays an increasingly important role in personalized medicine. At present, more than 100 drug instructions approved by the US FDA indicate that it is necessary to pay attention to the effect of genotype on the drug effects. Therefore, many genotyping technologies have emerged. Although these genotyping techniques are quite different, they are essentially based on four principles: nucleic acid hybridization, extension, enzymatic digestion, and ligation. According to these four principles, different genotyping detection technology platforms have been developed. Each of these technologies has advantages and disadvantages, and the scope of application varies (as shown in Table 11.1). We need to choose the appropriate genotyping technology for different purposes. For example, high-throughput detection techniques are often required when screening drug-related gene polymorphism sites. Thus, gene chip or NGS is a better choice for high-throughput screening of drug-related gene polymorphism sites. If the number of gene polymorphism sites to be detected is small, real-time PCR or pyrosequencing can be easily achieved. Therefore, understanding the principles of these genotyping techniques will help us to choose a right technology for a right detection target. Among these genotyping technologies, sequencing has the highest accuracy, and the detection results of other methods generally need to be verified by sequencing. Therefore, sequencing has always been the gold standard for genotyping. As the cost of NGS continues to decrease, we believe it will eventually become the most important genetic testing tool in the field of personalized medicine.
References
Chen Z, Cheng K, Walton Z et al (2012) A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 483(7391):613–617
Price MJ, Murray SS, Angiolillo DJ et al (2012) Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (genotype information and functional testing) study. J Am Coll Cardiol 59(22):1928–1937
Sagar M, Tybring G, Dahl ML et al (2000) Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism. Gastroenterology 119(3):670–676
McLeod HL (2013) Cancer pharmacogenomics: early promise, but concerted effort needed. Science 339(6127):1563–1566
Prawira A, Pugh TJ, Stockley TL et al (2017) rata resources for the identification and interpretation of actionable mutations by clinicians. Ann Oncol 28(5):946–957
Nagaraj S, Ramlal S, Venkataswamachari BP et al (2016) Differentiation of entC1 from entC2/entC3 with a single primer pair using simple and rapid SYBR green-based RT-PCR melt curve analysis. Appl Microbiol Biotechnol 100(19):8495–8506
Frade JP, Warnock DW, Arthington-Skaggs BA (2004) Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J Clin Microbiol 42(5):2085–2093
Chambliss AB, Resnick M, Petrides AK et al (2017) Rapid screening for targeted genetic variants via high-resolution melting curve analysis. Clin Chem Lab Med 55(4):507–516
Eizuka M, Sugai T, Habano W et al (2017) Molecular alterations in colorectal adenomas and intramucosal adenocarcinomas defined by high-density single-nucleotide polymorphism arrays. J Gastroenterol 52(11):1158–1168
Caputo TM, Battista E, Netti PA et al (2019) Supramolecular microgels with molecular beacons at the interface for ultrasensitive, amplification-free, and SNP-selective miRNA fluorescence detection. ACS Appl Mater Interfaces 11(19):17147–17156
Lu Y, Ma X, Wang J et al (2017) Visualized detection of single-base difference in multiplexed loop-mediated isothermal amplification amplicons by invasive reaction coupled with oligonucleotide probe-modified gold nanoparticles. Biosens Bioelectron 90:388–393
Chen Z, Miao L, Liu Y et al (2017) A universal genotyping-microarray constructed by ligating a universal fluorescence-probe with SNP-encoded flaps cleaved from multiplex invasive reactions. Chem Commun (Camb) 53(96):12922–12925
Wang J, Zou B, Ma Y et al (2017) Closed-tube PCR with nested serial invasion probe visualization using gold nanoparticles. Clin Chem 63(4):852–860
Hessner MJ, Budish MA, Friedman KD (2000) Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin Chem 46(8 Pt 1):1051–1056
Xiang Z, Wan R, Zou B et al (2018) Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA. Anal Bioanal Chem 410(26):6751–6759
Sheng N, Zou B, Tong H et al (2019) Sequence-encoded quantitative invader assay enables highly sensitive hepatitis B virus DNA quantification in a single tube without the use of a calibration curve. Analyst 144(19):5775–5784
Liu Y, Wu H, Zhou Q et al (2017) Digital quantification of gene methylation in stool DNA by emulsion-PCR coupled with hydrogel immobilized bead-array. Biosens Bioelectron 92:596–601
Acosta KB, Lorenzini Campos MN, Etcheverry SB et al (2016) α6β4 integrin genetic variations (A380T and R1281W) and breast cancer risk in an Argentinian population. Int J Mol Sci 17(10):E1540
Faghih Z, Abtahi S, Khademi B et al (2019) Association of OX40 gene polymorphisms (rs17568G/A and rs229811A/C) with head and neck squamous cell carcinoma. Mol Biol Rep 46(3):2609–2616
Zheng D, Chen Y, Gao C et al (2014) Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer. Cancer Biol Ther 15(11):1542–1551
Lau BT, Ji HP (2019) Covalent “click chemistry”-based attachment of DNA onto solid phase enables iterative molecular analysis. Anal Chem 91(3):1706–1710
Rejali NA, Moric E, Wittwer CT (2018) The effect of single mismatches on primer extension. Clin Chem 64(5):801–809
Doherty AJ, Suh SW (2000) Structural and mechanistic conservation in DNA ligases. Nucleic Acids Res 28(21):4051–4058
Zhao W, Ali MM, Brook MA et al (2008) Rolling circle amplification: applications in nanotechnology and biodetection with functional nucleic acids. Angew Chem Int Ed Engl 47(34):6330–6337
Ali MM, Su S, Filipe CD et al (2007) Enzymatic manipulations of DNA oligonucleotides on microgel: towards development of DNA-microgel bioassays. Chem Commun (Camb) 43:4459–4461
Li XH, Zhang XL, Wu J et al (2019) Hyperbranched rolling circle amplification (HRCA)-based fluorescence biosensor for ultrasensitive and specific detection of single-nucleotide polymorphism genotyping associated with the therapy of chronic hepatitis B virus infection. Talanta 191:277–282
Polidoros AN, Pasentsis K, Tsaftaris AS (2006) Rolling circle amplification-RACE: a method for simultaneous isolation of 5′ and 3′ cDNA ends from amplified cDNA templates. Biotechniques 41(1):35–36, 38, 40 passim
Dahl F, Baner J, Gullberg M et al (2004) Circle-to-circle amplification for precise and sensitive DNA analysis. Proc Natl Acad Sci U S A 101(13):4548–4553
Lizardi PM, Huang X, Zhu Z et al (1998) Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet 19(3):225–232
Schouten JP, McElgunn CJ, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30(12):e57
Schrijver I, Rappahahn K, Pique L et al (2008) Multiplex ligation-dependent probe amplification identification of whole exon and single nucleotide deletions in the CFTR gene of Hispanic individuals with cystic fibrosis. J Mol Diagn 10(4):368–375
Basu S, Needham LM, Lando D et al (2018) FRET-enhanced photostability allows improved single-molecule tracking of proteins and protein complexes in live mammalian cells. Nat Commun 9(1):2520
Tran T, Kostecki R, Catton M et al (2018) Utility of a stressed single nucleotide polymorphism (SNP) real-time PCR assay for rapid identification of measles vaccine strains in patient samples. J Clin Microbiol 56(8):e00360–e00318
Nagy A, Vitaskova E, Cernikova L et al (2017) Evaluation of TaqMan qPCR system integrating two identically labelled hydrolysis probes in single assay. Sci Rep 7:41392
Liu XP, Hou JL, Liu JH (2010) A novel single nucleotide polymorphism detection of a double-stranded DNA target by a ribonucleotide-carrying molecular beacon and thermostable RNase HII. Anal Biochem 398(1):83–92
Kong DM, Gu L, Shen HX et al (2002) A modified molecular beacon combining the properties of TaqMan probe. Chem Commun (Camb) 8:854–855
Rickert AM, Ballvora A, Matzner U et al (2005) Quantitative genotyping of single-nucleotide polymorphisms by allele-specific oligonucleotide hybridization on DNA microarrays. Biotechnol Appl Biochem 42(Pt 1):93–96
Su C, Hott C, Brownstein BH et al (2004) Typing single-nucleotide polymorphisms in toxoplasma gondii by allele-specific primer extension and microarray detection. Methods Mol Biol 270:249–262
Li Y, Tang J, Pan Z et al (2011) Single nucleotide polymorphism genotyping and point mutation detection by ligation on microarrays. J Nanosci Nanotechnol 11(2):994–1003
Cronin MT, Fucini RV, Kim SM et al (1996) Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays. Hum Mutat 7(3):244–255
Glas AM, Floore A, Delahaye LJ et al (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278
McBean RS, Hyland CA, Flower RL (2015) Blood group genotyping: the power and limitations of the Hemo ID panel and MassARRAY platform. Immunohematology 31(2):75–80
Trewick AL, Moustafa JS, de Smith AJ et al (2011) Accurate single-nucleotide polymorphism allele assignment in trisomic or duplicated regions by using a single base-extension assay with MALDI-TOF mass spectrometry. Clin Chem 57(8):1188–1195
Mauger F, Gelfand DH, Gupta A et al (2013) High-specificity single-tube multiplex genotyping using Ribo-PAP PCR, tag primers, alkali cleavage of RNA/DNA chimeras and MALDI-TOF MS. Hum Mutat 34(1):266–273
Bauer DC, Gaff C, Dinger ME et al (2014) Genomics and personalised whole-of-life healthcare. Trends Mol Med 20(9):479–486
Rohlin A, Wernersson J, Engwall Y et al (2009) Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat 30(6):1012–1020
Yin AA, He YL, Etcheverry A et al (2019) Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas. Clin Epigenetics 11(1):76
Hook SE, Twine NA, Simpson SL et al (2014) 454 pyrosequencing-based analysis of gene expression profiles in the amphipod Melita plumulosa: transcriptome assembly and toxicant induced changes. Aquat Toxicol 153:73–88
Jing H, Song Q, Chen Z et al (2011) Dye-free microRNA quantification by using pyrosequencing with a sequence-tagged stem-loop RT primer. Chembiochem 12(6):845–849
Blumenthal GM, Mansfield E, Pazdur R (2016) Next-generation sequencing in oncology in the era of precision medicine. JAMA Oncol 2(1):13–14
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Zou, B., Sheng, N., Feng, L., Zhou, G. (2020). Genotyping Technologies in Pharmacogenomics. In: Cai, W., Liu, Z., Miao, L., Xiang, X. (eds) Pharmacogenomics in Precision Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-15-3895-7_11
Download citation
DOI: https://doi.org/10.1007/978-981-15-3895-7_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-3894-0
Online ISBN: 978-981-15-3895-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)